Short answer. Olive oil polyphenols — chiefly hydroxytyrosol and its derivatives — are the compounds behind the cardiovascular research on extra virgin olive oil, and the peppery catch at the back of the throat is roughly where you taste them. Early-harvest fruit pressed within hours carries far more of them than late-harvest oil. The specific regulator-recognised claim, that olive oil polyphenols help protect blood lipids from oxidative stress, applies to oils containing at least 5 mg of hydroxytyrosol and derivatives per 20 g. That is a laboratory measurement, so we will print it on a batch when that batch has been tested, and not before.
What the research supports
A 2018 review in Endocrine, Metabolic & Immune Disorders Drug Targets examined extra virgin olive oil supplementation in both healthy people and people at cardiovascular risk, and concluded that it acts as an anti-inflammatory, antioxidant and vasodilatory nutrient that may contribute to lowering the atherosclerotic burden. Fatty acids make up 98 to 99 per cent of the oil; the remaining one to two per cent — polyphenols, tocopherols and other minor compounds — is where most of that activity sits.
The regulator-recognised wording is narrower and more precise than the general research, and it is worth quoting exactly: olive oil polyphenols contribute to the protection of blood lipids from oxidative stress. It is tied to a measured threshold of at least 5 mg of hydroxytyrosol and its derivatives per 20 g of oil.
The largest trial: a diet pattern built on this oil
The strongest cardiovascular evidence does not come from a bottle in isolation — it comes from PREDIMED, which randomised 7,447 people at high cardiovascular risk to a Mediterranean diet supplemented with extra virgin olive oil, the same diet supplemented with nuts, or a control diet advised to cut fat. Major cardiovascular events were around 30 per cent lower in both Mediterranean arms than in the control arm.
Two honest notes belong with that number. The first: the trial tested a dietary pattern in which extra virgin olive oil is the central fat, not a supplement taken on its own, so the fair claim is about the pattern and the oil at its centre — not about any single bottle preventing a heart attack.
The second: the 2013 publication of PREDIMED was retracted and republished in 2018 after irregularities were found in how some participants were randomised. The corrected reanalysis, which is the version we cite, left the conclusions substantially unchanged. We would rather tell you that than have you find it out elsewhere; a page that hides a retraction is not a page worth citing.
Why the harvest window decides it
Polyphenol content is highest in green, early-harvest fruit and falls as olives ripen. It falls again with delay between picking and pressing, and again with heat during extraction. Early harvest, cold extraction within 24 hours, and a single named grove are not romantic details — each one is a step that keeps those compounds in the bottle.
You can taste the consequence. The bitterness and the peppery cough at the back of the throat come largely from those same phenolic compounds. A mild, buttery oil is a pleasant oil; it is not usually a high-polyphenol one.
What we will not say until it is measured
We do not print a polyphenol number for our oil, because we have not had our batch analysed. When a batch is tested we will publish the figure and the laboratory that produced it, and if it clears the threshold we will say so in the recognised wording. Until then the honest claim is about process and harvest, not milligrams.
One correction for the record: an earlier version of this page cited two PubMed identifiers that point at unrelated papers — one on food emulsions, one on ultrasound therapy. Both are gone. The citation below resolves to the review it names.
Read it yourself
Estruch R, Ros E, Salas-Salvadó J, et al. "Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts." New England Journal of Medicine, 2018;378(25):e34. doi:10.1056/NEJMoa1800389 — the retracted-and-republished PREDIMED analysis, https://pubmed.ncbi.nlm.nih.gov/29897866/
Nocella C, Cammisotto V, Fianchini L, D’Amico A, Novo M, Castellani V, Stefanini L, Violi F, Carnevale R. "Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health." Endocrine, Metabolic & Immune Disorders Drug Targets, 2018. doi:10.2174/1871530317666171114121533 — https://pubmed.ncbi.nlm.nih.gov/29141571/